EEG spectral abnormalities and psychosis as predictors of cognitive and functional decline in probable Alzheimer's disease

Neurology
Oscar L LopezSteven T DeKosky

Abstract

We examined whether either psychotic features (e.g., delusions and hallucinations) or EEG abnormalities are associated with more rapid progression of Alzheimer's disease (AD). AD patients with psychosis have exhibited more EEG abnormalities than those without psychosis, and both abnormal EEG and psychosis have been noted to be predictors of functional and cognitive decline in AD. Ninety-five probable AD patients participating in a longitudinal study of dementia had an EEG and a semistructured psychiatric interview at baseline. Using EEG spectral analysis, we classified records as normal/abnormal based on the parasagittal mean frequency. Patients with abnormal EEGs were more functionally (e.g., Blessed Rating Scale for activities of daily living) and cognitively (e.g., Mini-Mental State) impaired than patients with normal EEG. AD patients with psychosis were only more functionally impaired than patients without psychosis. A two-factor analysis showed no interaction between abnormal EEG and psychosis. In addition, using a Cox proportional hazard model adjusted for age and education, the presence of an abnormal EEG or psychotic symptom at study entry was associated with higher risk of reaching severe cognitive and functional impai...Continue Reading

Citations

Oct 12, 2005·Archives of Neurology·Nikolaos ScarmeasYaakov Stern
Jan 9, 2004·La Revue de médecine interne·C DumontB Vellas
Jul 5, 2003·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Donatella MattiaMaria Grazia Marciani
Jul 10, 1999·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·J J ClausW A van Gool
Nov 26, 2008·International Psychogeriatrics·Matt ParadiseGill Livingston
Dec 13, 2005·Aging & Mental Health·C FischerS B Rourke
Dec 22, 1999·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·F NobiliG Rodriguez
Jul 15, 2000·Journal of Neurology, Neurosurgery, and Psychiatry·R S WilsonD A Evans
Mar 19, 2005·Dementia and Geriatric Cognitive Disorders·Maristella PiccininniDomenico Inzitari
Dec 15, 2005·Neuroepidemiology·R S WilsonD A Evans
Aug 12, 2006·Dementia and Geriatric Cognitive Disorders·Corinne FischerSean B Rourke
Sep 18, 2015·Issues in Mental Health Nursing·Ezra C Holston
Nov 4, 2010·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Oscar L LopezRachel Schindler
Feb 7, 2001·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·S TekinJ L Cummings
Jul 31, 2007·Neurologic Clinics·Tanis J Ferman, Bradley F Boeve
Oct 27, 2005·International Journal of Geriatric Psychiatry·Dimitrios AdamisAdrian Treloar
Feb 4, 2009·International Journal of Geriatric Psychiatry·Matt ParadiseGill Livingston
Apr 3, 2010·Neurobiology of Aging·Neelesh K NadkarniSandra E Black
Jun 2, 2011·International Journal of Alzheimer's Disease·Guido RodriguezAgnese Picco
Nov 11, 1999·International Journal of Geriatric Psychiatry·M SchäufeleS Weyerer
Mar 9, 2004·American Journal of Alzheimer's Disease and Other Dementias·Corinne FischerMireille Norris
Aug 2, 2006·Journal of Geriatric Psychiatry and Neurology·Dilip V JesteGeorge S Zubenko
Jul 11, 1998·International Journal of Geriatric Psychiatry·N Gormley, M R Rizwan
Jan 15, 2021·Molecular Neurodegeneration·Jeffrey Cummings
Oct 3, 2002·Experimental Neurology·James BenvenutoRichard Granger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here